A recent study revealed that hY4 RNA fragments are upregulated in human small-cell lung cancer-derived EVs and inhibit tumor development by inhibiting MAPK/NF-kB signaling [40]. The gene discussed is RNY4; the disease is small cell lung carcinoma.